The aim of this work has been to isolate and characterize new diploid cell strains, suitable for large-scale production of human fibroblast interferon. Twenty cell strains were isolated from individual neonatal foreskins obtained with the informed consent of the donors' parents. The techniques employed for the isolation of the cell strains were aimed at obtaining the highest possible yield of normal diploid cells, free of contaminating microorganism and viruses. The bulk of the cell yield has been frozen at a low population doubling level. Each of the isolated cultures was tested for interferon producing characteristics with poly(I)-poly(C) under a number of different conditions including "superinduction" with metabolic inhibitors. Most of the newly established cell strains produced lower interferon yields than the reference FS-4 cell strain. However, some new cell strains produced similar interferon yields as the FS-4 cells on superinduction. Five cell strains, designated FS-30, FS-35, FS-44, FS-48 and FS-49, identified as the highest interferon producers among the new cells, were selected for further testing. Of these, three cell strains (FS-35, FS-48 AND FS-49) produced similar interferon yields as FS-4 cells after superinduction. Cell strains FS-48 and FS-49 were found to have stable interferon producing characteristics over a wide span of population doubling levels. The interferon produced in these new cell strains had the antigenic and biological characteristics of human fibroblast interferon.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4615-9080-4_9DOI Listing

Publication Analysis

Top Keywords

cell strains
40
cell
12
interferon yields
12
fs-48 fs-49
12
strains
10
interferon
10
human fibroblast
8
fibroblast interferon
8
population doubling
8
interferon producing
8

Similar Publications

Antibiotic-resistant strains of Staphylococcus aureus pose a significant threat in healthcare, demanding urgent therapeutic solutions. Combining bacteriophages with conventional antibiotics, an innovative approach termed phage-antibiotic synergy, presents a promising treatment avenue. However, to enable new treatment strategies, there is a pressing need for methods to assess their efficacy reliably and rapidly.

View Article and Find Full Text PDF

Propidium Monoazide is Unreliable for Quantitative Live-Dead Molecular Assays.

Anal Chem

January 2025

Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, Indiana 47907, United States.

Propidium monoazide (PMA) is a dye that distinguishes between live and dead cells in molecular assays like the Polymerase Chain Reaction (PCR). It works by cross-linking to the DNA of cells that have compromised membranes or extracellular DNA upon photoactivation, making the DNA inaccessible for amplification. Currently, PMA is used to detect viable pathogens and alleviate systemic bias in the microbiome analysis of samples using 16S rRNA gene sequencing.

View Article and Find Full Text PDF

Growth inhibition by ppc deletion is rescued by isocitrate dehydrogenase mutations in Escherichia coli.

FEMS Microbiol Lett

January 2025

Department of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita, Osaka 565-0871, Japan.

Phosphoenolpyruvate carboxylase encoded by ppc catalyzes the anaplerotic reaction of oxaloacetate in the TCA cycle in Escherichia coli. Deletion of ppc does not prevent the cells from replenishing oxaloacetate via the glyoxylate shunt, but the ppc-deletion strain almost did not grow on glucose. In the present study, we obtained evolved strains by deleting both ppc and mutS to increase the mutation rate and investigated the mechanisms for improving growth by analyzing the mutated genes.

View Article and Find Full Text PDF

Selective pressure of various levels of erythromycin on the development of antibiotic resistance.

Environ Pollut

January 2025

Civil and Construction Engineering and Environmental and Ecological Engineering, Purdue University, 550 Stadium Mall Drive, West Lafayette, Indiana, United States 47907. Electronic address:

This study evaluated microbial fitness under selective pressure of various erythromycin concentrations and the development of resistance genes in Escherichia coli (E. coli) and Enterococcus faecalis (E. faecalis).

View Article and Find Full Text PDF

Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection.

Antiviral Res

January 2025

CIRI, Centre International de Recherche en Infectiologie, INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon, 21 Avenue Tony Garnier, 69007 Lyon, France.

Nipah virus (NiV) is a lethal zoonotic paramyxovirus that can be transmitted from person to person through the respiratory route. There are currently no licensed vaccines or therapeutics. A lipopeptide-based fusion inhibitor was developed and previously evaluated for efficacy against the NiV-Malaysia strain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!